Oesophageal cancer metastases:An observational study of a more aggressive approach  

作　　者：Lianne Pickett Mary Dunne Orla Monaghan Liam Grogan Oscar Breathnach Thomas N Walsh 

机构地区：[1]Department of Surgery,Connolly Hospital,Blanchardstown,Dublin D15 X40D,Ireland [2]Clinical Trials Resource Unit,St Luke's Radiation Oncology Network,Dublin D06 HH36,Ireland [3]Department of Radiation Oncology,St Luke's Radiation Oncology Network,Dublin D06 HH36,Ireland [4]Department of Medical Oncology,Beaumont Hospital,Dublin D09 V2N0,Ireland [5]Department of Surgery,RCSI Bahrain,Adliya 15503,Bahrain

出　　处：《World Journal of Gastrointestinal Surgery》2022年第9期997-1007,共11页世界胃肠外科杂志（英文版）（电子版）

摘　　要：BACKGROUND The prognosis for oesophageal carcinoma is poor,but once distant metastases emerge the prognosis is considered hopeless.There is no consistent protocol for the early identification and aggressive management of metastases.AIM To examine the outcome of a policy of active postoperative surveillance with aggressive treatment of confirmed metastases.METHODS A prospectively maintained database of 205 patients diagnosed with oesophageal carcinoma between 1998 and 2019 and treated with curative intent was interrogated for patients with metastases,either at diagnosis or on follow-up surveillance and treated for cure.This cohort was compared with incomplete clinical responders to neoadjuvant chemoradiotherapy(nCRT)who subsequently underwent surgery on their primary tumour.Overall survival was estimated using the Kaplan-Meier method,and the log-rank test was used to compare survival differences between groups.RESULTS Of 205 patients,11(5.4%)had metastases treated for cure(82%male;median age 60 years;9 adenocarcinoma and 2 squamous cell carcinomas).All had undergone neoadjuvant chemotherapy or chemoradiotherapy,followed by surgery in all but 1 case.Of the 11 patients,4 had metastatic disease at diagnosis,of whom 3 were successfully downstaged with nCRT before definitive surgery;2 of these 4 also developed oligometastatic recurrence and were treated with curative intent.Following definitive treatment,7 had treatment for metachronous oligometastatic disease;5 of whom underwent metastasectomy(adrenal×2;lung×2;liver×1).The median overall survival was 10.9 years[95%confidence interval(CI):0.7-21.0 years],which was statistically significantly longer than incomplete clinical responders undergoing surgery on the primary tumour without metastatic intervention[n=62;median overall survival=1.9(95%CI:1.1-2.7;P=0.012].The cumulative proportion surviving 1,3,and 5 years was 100%,91%,and 61%,respectively compared to 71%,36%,and 25%for incomplete clinical responders undergoing surgery on the primary tumour who did not undergo

关 键 词：Oesophageal metastases OLIGOMETASTASES Active surveillance Treatment for cure METASTASECTOMY Survival 

分 类 号：R735.1[医药卫生—肿瘤]